Ethylenediamine, profile of a sensitizing excipient - International Journal of Clinical Pharmacy
- ️Zuidema, J.
- ️Thu Aug 01 1985
Elias JA, Levinson I. Hypersensitivity reactions to aminophylline. Am Rev Respir Dis 1981;123:550–2.
Cotgreave IA, Caldwell J. Comparative plasma pharmacokinetics of theophylline and ethylenediamine after administration of aminophylline to man. J Pharm Pharmacol 1983;35:378–82.
Turner A, Osol A. The spectrophotometric determination of the dissociation of theophylline. J Am Pharm Assoc [Sci] 1949;38:158.
Yevstratova KI, Ivanova AI. Dissociation constants and methods for analyses of some organic bases. (In Russian.) Farmaciya 1968;17:41.
Cotgreave IA, Caldwell J. Physicochemical andin vitro biological studies on the possible association between theophylline and ethylenediamine in solution. J Pharm Pharmacol 1983;35:774–9.
Tashma Z. NMR study of theophylline-ethylenediamine interactions in aqueous solution. J Pharm Pharmacol 1984;36:758–60.
Zuidema J. Physical and chemical properties of xanthine derivatives. In: Merkus FWHM, Hendeles L, eds. Sustained release theophylline. Amsterdam: Excerpta Medica, 1983:11–27.
White MI, Douglas WS, Main RA. Contact dermatitis attributed to ethylenediamine. Br Med J 1978;1:415–6.
Eriksen KE. Allergy to ethylenediamine. Arch Dermatol 1975;111:791.
Tas J, Weissberg D. Allergy to aminophylline. Acta Allergol 1958;12:39–42.
Baer RL, Cohen HJ, Neidorff AH. Allergic eczematous sensitivity to aminophylline. Arch Dermatol 1959;79:647–8.
Eberhartiger C. Kontaktallergie gegen äthylendiamin. Hautarzt 1964;15:450–1.
Epstein E, Maibach HJ. Ethylenediamine. Arch Dermatol 1968;98:476–7.
Hjorth N. Dermatitis from ethylenediamine. Contact Dermatitis Newsletter 1969;5:107.
Maibach H, Epstein E. Ethylenediamine sensitivity. Contact Dermatitis Newsletter 1971;9:207.
Fisher AA. The broad implications of allergic sensitization to ethylenediamine hydrochloride. Contact Dermatitis Newsletter 1973;14:418–23.
Cronin E. Contact dermatitis. Edinburgh: Churchill Livingstone, 1980.
Dooms-Goossens A. Allergic contact dermatitis to ingredients used in topically applied pharmaceutical products and cosmetics. Leuven: Catholic University of Leuven, 1982. Dissertation.
Fisher AA. Ethylenediamine dermatitis. Arch Dermatol 1969;100:519–20.
Van Hecke E. Ethylenediamine sensitivity from exposure to epoxy resin hardeners and MycologsR cream. Contact Dermatitis 1975;1:344–8.
Provost TT, Jillson OF. Ethylenediamine contact dermatitis. Arch Dermatol 1967;96:231–4.
Fisher AA. Contact dermatitis. Philadelphia: Lea and Febiger, 1973.
De Shazo RD, Stevenson HC. Generalized dermatitis to aminophylline. Ann Allergy 1981:46:152–5.
Hardy C, Schofield O, George CF. Allergy to aminophylline. Br Med J 1983;286:2051–2.
Petrozzi JW, Shore RN. Generalized exfoliative dermatitis from ethylenediamine. Arch Dermatol 1976;112:525–6.
Bernstein JE, Lorincz AL. Ethylenediamine-induced exfoliative erythroderma. Arch Dermatol 1979;115:360–1.
Van den Berg WHHW, Van Ketel WG. Contactallergie voor ethyleendiamine. Ned Tijdschr Geneeskd 1983;127:1801–2.
Lawyer CH, Bardana EJ, Rodgers R, Gerber N. Utilization of intravenous dihydroxypropyltheophylline in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline. J Allergy Clin Immunol 1980;65:353–7.
Booth BH, Coleman WP, Mitchell DQ. Urticaria following intravenous aminophylline. Ann Allergy 1979;43:289–90.
Lam S, Chan-Yeung M. Ethylenediamine-induced asthma. Am Rev Respir Dis 1980;121:151–5.
Fisher AA. Allergic paraben and benzylalcohol hypersensitivity relationship of the ‘delayed’ and ‘immediate’ varieties. Contact Dermatitis 1975;1:281–4.
Wong D, Lopapa AF, Haddad ZH. Immediate hypersensitivity reaction to aminophylline. J Allergy Clin Immunol 1971;48:165–70.
Fisher AA. Instructions for the ethylenediamine-sensitive patient. Cutis 1974;13:27–8.
White MI. Contact Dermatitis from ethylenediamine. Contact Dermatitis 1978;4:291–3.
Calnan CD. Occupational piperazine Dermatitis. Contact Dermatitis 1975;1:126.
Burry JN. Ethylenediamine sensitivity with a systemic reaction to piperazine citrate. Contact Dermatitis 1978;4:380.
Wright S, Harman RRH. Ethylenediamine and piperazine sensitivity. Br Med J 1983;287:463–4.
Rudzki E, Krajenska D. Cross-reactions between ethylenediamine, diethylenetriamine and triethylenetetramine. Contact Dermatitis 1976;2:311–3.
Epstein E. Negative patchtests to ethylenediaminetetra-acetate in patients allergie to ethylenediamine. Contact Dermatitis Newsletter 1974;16:475.
Raymond JZ, Gross PR. EDTA: preservative dermatitis. Arch Dermatol 1969;100:436.
Caldwell J, Cotgreave IA. Comparative disposition of theophylline and ethylenediamine given as aminophylline to human volunteers. Br J Clin Pharmacol 1982;14:610 P.
Caldwell J, Cotgreave IA. Verteilung von Theophyllin and Ethylendiamin verabreicht als Theophyllin-Ethylendiamin bei Probanden. Therapiewoche 1983;33:969–76.
Caldwell J, Cotgreave IA. An HPLC assay for ethylenediamine in plasma and urine. Br J Pharmacol 1982;77:419P.
Caldwell J, Cotgreave IA. The metabolism of ethylenediamine in the rat. Br J Pharmacol 1983;78:62 P.
Markiw RT. Isolation ofN-acetylethylenediamine from urine of patients on Amesec. Biochem Med 1975;14:152–5.
McGinity JW, Brown RL. Stabilizing effect of inorganic phosphate salts on antibiotic-steroid ophthalmic preparations. J Pharm Sci 1975;64:1528–30.
Bülow KB, Larsson H, Leideman T. Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation. Eur J Clin Pharmacol 1975;8:115–8.
Jonkman JHG, Holtkamp-Zieleman MB, Hoff-van den Berg EM, Grimberg N, Schoenmaker R. Oploskarakteristieken van enkele cholinetheofyllinaattabletten. Pharm Weekbl 1981;116:665–71.
Curtis GH, Crawford PF. Cutaneous sensitivity to monoglycerol para-aminobenzoate. Cleve Clin Q 1951;35–40.
Martindale. The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982.
Zuidema J, Merkus FWHM. Chemical and biopharmaceutical aspects of theophylline and its derivatives. Curr Med Res Opin 1979;6:14S-25S.
French IW, Mildon CA. The pharmacokinetics of theophylline. Curr Med Res Opin 1979;6:3S-13S.
Tukker JJ, De Blaey CJ. Prolonged storage of aminophylline suppositories. Pharm Weekbl [Sci] 1984;6:96–8.
FNA. Formulary of the Dutch Pharmacists. The Hague: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 1979.
Zuidema J, Merkus FWHM. Pharmacokinetics and pharmacodynamics of diprophylline. Pharm Weekbl [Sci] 1981;3:216–21.
Monks TJ, Smith RL, Caldwell J. A metabolic and pharmacokinetic comparison of theophylline and aminophylline. J Pharm Pharmacol 1981;33:93–7.
Caldwell J, Monks TJ, Smith RL. A comparison of the metabolism and pharmacokinetics of intravenously administered theophylline and aminophylline in man. Br J Pharmacol 1978;63:369P-70P.
Caldwell J, Cotgreave IA. Plasma protein binding and distribution in the blood of theophylline and aminophylline. Br J Pharmacol 1981;74:876–7P.
Aslaksen A, Bakke OM, Vigander T. Comparative pharmacokinetics of theophylline and aminophylline in man. Br J Clin Pharmacol 1981;11:269–73.
Zimmerman I, Schulz HU, Ulmer WT. Blutspiegelverlauf bei intravenöser, intramuskulärer und oraler Gabe von Theophyllin-aethylendiamin und neutral gelöstem Theophyllin. Arzneim Forsch 1978;28:1652–4.
Baccouche M, Dittman EC, Eltze M, Kilian U. Ethylendiamine —Pharmakologie von Aethylendiamin und dessen Wechselwirkung mit Theophyllin. Prax Klin Pneumol 1983;37:322–5.
Stone TW, Perkins MN. Ethylenediamine as a GABA-mimetic. TIPS 1984;241–3.
Greif N. Cutaneous safety of fragrance material as measured by the maximization test. Am Perf and Cosm 1967;82:54–7.